The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial intelligence, emphasizing the need to reduce regulatory burdens that hinder innovation and increase costs, while ensuring patient safety and data privacy. The letter outlines four key recommendations: synchronizing AI policies with existing frameworks to avoid redundancy, removing regulatory barriers such as fragmented privacy laws and outdated substance use disorder regulations, ensuring safe and effective AI use through clinician involvement in decision loops that impact care delivery and consistent standards for third-party vendors, and addressing organizational and infrastructural challenges by aligning incentives and investing in digital access and literacy. The AHA encourages OSTP to ensure balanced, flexible policies that support innovation and improve care delivery across the health system. 

Related News Articles

Headline
The Department of Health and Human Services Dec. 4 released its strategy on integrating artificial intelligence across internal operations, research and public…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Trump administration issued an executive order Nov. 24 launching the Genesis Mission, an artificial intelligence initiative focusing on scientific research…
Blog
Public
The health care field has entered a period of disruption, from sweeping coverage changes to the rise of artificial intelligence (AI)-enabled tools. The…
Headline
AHA leaders tomorrow will participate in a series of panels during the International Hospital Federation’s 48th annual World Hospital Congress in Geneva. AHA…
Headline
The AHA Oct. 23 recommended changes to the Centers for Medicare & Medicaid Services’ Wasteful and Inappropriate Services Reduction model to address…